T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Hexcel
HXL
$7.81B
| $78.9M | 0.02% |
1,585,550
+48,474
| +3% | +$2.44M |
|
|
LPNT
677
DELISTED
LifePoint Health, Inc.
LPNT
| $78.9M | 0.02% |
906,927
-300
| -0% | -$22.7K |
|
|
NBIS
678
Nebius Group N.V.
NBIS
$73B
| $77.9M | 0.02% |
5,116,393
-1,840,300
| -26% | -$33.6M |
|
679
NextEra Energy
NEE
$180B
| $77.7M | 0.02% |
3,170,412
+41,080
| +1% | +$1.04M |
|
680
Mativ Holdings
MATV
$663M
| $77.6M | 0.02% |
1,945,339
+101,950
| +6% | +$4.32M |
|
681
Marvell Technology
MRVL
$198B
| $77.2M | 0.02% |
5,853,562
-2,186,276
| -27% | -$31.4M |
|
682
Badger Meter
BMI
$3.79B
| $76.8M | 0.02% |
2,420,612
+668,792
| +38% | +$21.1M |
|
683
Boston Beer
SAM
$1.91B
| $76.3M | 0.02% |
328,802
+8,973
| +3% | +$2.31M |
|
|
BNCL
684
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $75.9M | 0.02% |
6,073,493
+5,122
| +0.1% | +$61.3K |
|
685
AZZ Inc
AZZ
$4.51B
| $75.8M | 0.02% |
1,463,979
+2,200
| +0.2% | +$107K |
|
686
Veeco
VECO
$3.17B
| $75.8M | 0.02% |
2,636,222
+158,152
| +6% | +$4.86M |
|
|
DENN
687
DELISTED
Denny's
DENN
| $75.7M | 0.02% |
6,519,909
+81,256
| +1% | +$907K |
|
688
Selective Insurance
SIGI
$5.61B
| $75.6M | 0.02% |
2,694,090
-7,700
| -0.3% | -$214K |
|
|
KNL
689
DELISTED
Knoll, Inc.
KNL
| $74.9M | 0.02% |
2,993,840
+11,170
| +0.4% | +$263K |
|
|
SWC
690
DELISTED
Stillwater Mining Co
SWC
| $74.8M | 0.02% |
6,449,871
+2,205,740
| +52% | +$29.8M |
|
|
MRO
691
DELISTED
Marathon Oil Corporation
MRO
| $74.6M | 0.02% |
2,810,568
-110,340
| -4% | -$3.11M |
|
|
CAM
692
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $74.5M | 0.02% |
1,423,000
+975,440
| +218% | +$50.6M |
|
|
RAVN
693
DELISTED
Raven Industries Inc
RAVN
| $74.5M | 0.02% |
3,662,580
-310,544
| -8% | -$6.28M |
|
694
Haemonetics
HAE
$4.14B
| $74.4M | 0.02% |
1,799,200
+507,920
| +39% | +$21.4M |
|
695
Advanced Energy
AEIS
$13.2B
| $74.3M | 0.02% |
2,702,790
-349,280
| -11% | -$9.48M |
|
696
NOV
NOV
$7.56B
| $74M | 0.02% |
1,532,211
-1,318,725
| -46% | -$67.8M |
|
|
B
697
Barrick Mining
B
$68.1B
| $73.6M | 0.02% |
6,900,890
+1,966,880
| +40% | +$24M |
|
698
Atmos Energy
ATO
$28.7B
| $73.3M | 0.02% |
1,429,202
+1,161,712
| +434% | +$62.2M |
|
|
FTR
699
DELISTED
Frontier Communications Corp.
FTR
| $73M | 0.02% |
983,020
+868,337
| +757% | +$77.4M |
|
700
Adobe
ADBE
$106B
| $72.9M | 0.02% |
899,677
+23,161
| +3% | +$1.81M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.